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Carnitine palmitoyl-transferase enzyme inhibition protects proximal
tubules during hypoxia. The role of inhibition of the CPT enzymes
responsible for accumulation of long chain acylcarnitines (LCAC) during
hypoxia in the proximal tubule has not been previously examined. We have
characterized CPT enzyme activities in mitochondrial fractions of rabbit
proximal tubules. Malonyl CoA-sensitive CPT I activity (1.1 0.3
nmol/min/mg protein), and detergent-solubilized, malonyl CoA-insensi-
tive CPT II activity (2.3 0.4 nmol/min/mg protein) were readily detected
in proximal tubule mitochondrial fractions. Subjecting rabbit proximal
tubules to various periods of hypoxia did not significantly change mito-
chondrial CPT I or CPT II activities. Thirty minutes of hypoxia resulted in
an increase in lysophospholipid mass from 440 105 to 720 93 pmol/mg
protein, N = 5, LCAC mass from 79 11 to 618 34 pmol/mg protein,N = 5, and lactate dehydrogenase (LDH) release from 9 1% to 46
3%, N = 8. Pretreatment of proximal tubules with two different CPT
inhibitors, glybenclamide (Glyb) 400 jM and oxfenicine (Oxfe) 1 mM,
resulted in reduction in the magnitude of hypoxia-induced lysophospho-
lipid formation 490 160 (Glyb), 342 150 pmol/mg protein (Oxfe), N =
4, hypoxia-induced LCAC formation 295 27 (Glyb), 128 16 pmol/mg
protein (Oxfe), N 5, and LDH release 25 1% (Glyb) and 19 2%
(Oxfe), N = 8. The protective effect of CPT inhibition was also associated
with increased production of lactate suggesting the modulation of a
substrate-mediated metabolic switch. Immunoblots demonstrated that
hypoxia caused a time dependent hydrolysis of fodrin-alpha subunit and
that CPT inhibition protected against hypoxia-induced fodrin proteolysis.
These data suggest a unitying hypothesis that links phospholipase A2
(PLA2) activation, and hypoxia-mediated fodrin proteolysis to the proxi-
mal tubule mitochondrial CPT system. I propose that CPT inhibition may
represent a novel mechanism to ameliorate proximal tubule cell death
during hypoxia.
Previous studies have demonstrated that ischemia/hypoxic in-
jury results in the rapid accumulation of both lysophospholipids
and long chain acylcarnitines (LCAC) in the proximal tubule
[1—3]. The formation of LCAC in the proximal tubule requires
active transport of long chain fatty acyl groups into the mitochon-
drial matrix to undergo /3-oxidation, a process carried out by the
mitochondrial earnitine palmitoyl transferase (CPT) enzyme sys-
tem [4, 5]. Two distinct classes of mitochondrial CPT enzymes
have been characterized [6—12]. CPT I, an integral outer mem-
brane protein, catalyzes the transfer of an acyl group from
coenzyme A to carnitine forming long chain acylcarnitines
(LCAC). The transesterification of LCAC is reversed by CPT II,
a protein associated with the matrix face of the inner membrane.
CPT I plays an important physiological role in the regulation of
the /3-oxidation pathway due to its unique inhibition by malonyl
CoA [5]. To date, there is no information available regarding the
CPT isoenzymes present in the proximal tubule or the potential
role of their regulation during hypoxic cell injury.
The present study was undertaken to: (1) characterize the CPT
enzyme system in the proximal tubule, (2) determine if CPT
inhibition was associated with protection against membrane dam-
age during hypoxia, and (3) to define the potential protein(s)
targeted by CPT inhibition during hypoxia-induced membrane
damage. This study demonstrates that two distinct mitochondrial
CPT proteins and enzyme activities participate in long chain fatty
acid oxidation in the proximal tubule. It also shows that CPT
inhibition by glybenclamide and oxfenicine markedly reduced
hypoxia-induced lactate dehydrogenase (LDH) release, long
chain acylcarnitine and lysophospholipid formation. Finally, since
there is direct evidence that protease-mediated hydrolysis of
fodrin, a major cytoskeletal protein, occurs during ischemia/
hypoxia and contributes to membrane damage [13—15], I exam-
ined whether fodrin becomes cleaved during hypoxia-induced
membrane damage. The experiments revealed that fodrin was
cleaved during hypoxia to a major detectable 150 kDa fodrin
fragment. Furthermore, fodrin cleavage was inhibited in hypoxic
tubules that exhibited marked protection against membrane dam-
age (oxfenicine treated). These studies provide further support
for an important pathophysiologic role for phospholipase A2
(PLA2) and protease-mediated fodrin proteolysis as a general
feature of hypoxia-induced cell death [15]. In addition, this study
shows for the first time that membrane damage during hypoxia
appears to be closely related to protease-mediated fodrin degra-
dation in the proximal tubule, Inhibition of proximal tubule
mitochondrial CPT enzymes may represent a novel therapeutic
approach to ameliorate hypoxia-mediated cell death.
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METHODS
Experimental design
Proximal tubules were isolated from kidney cortex of New
Zealand white rabbits by collagenase digestion and Pereoll gradi-
ent separation as previously described [16]. Final tubule pellets
were resuspended at a concentration of 3 mg protein/mi in
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ice-cold 95% 02/5% C02-gassed DME/F12 media. Each experi-
ment was initiated with a 20-minutes pre-equilibration period of
the tubule suspension at 37°C in DME/F12 media bubbled with
95% 02/5% CO2. For hypoxic studies, tubule suspensions were
gassed with 95% N2/5% CO2 and incubated for various times
prior to sampling for lactate dehydrogenase release (LDH). LDH
was measured spectrophotometrically on Triton-permeabilized
0.5 ml aliquots of tubule suspensions and corresponding superna-
tants as described [3]. Protein concentrations of the suspensions
were measured by the Lowry method [17].
ATP measurements
The effect of hypoxia and CPT inhibition on the ATP content of
freshly isolated rabbit proximal tubules was determined using the
luciferin-luciferase assay (Sigma Chemical Co., St. Louis, MO,
USA) as previously described [18]. Briefly, after proximal tubules
were subjected to various experimental conditions 1 ml of tubule
suspension was centrifuged at 14,000 rpm for two minutes. The
supernatant was discarded and the cells were extracted with 400 d
of 2% perchloric acid. A 20 jil sample of the PCA extract was
neutralized with NaOH and diluted with 10 mivi Tris(hydroxy-
methyl)-methyl-2-aminoethanesulfonic acid (pH 7.4). A 20 pi
sample of the diluted cell extract was mixed with 100 l of
luciferin-luciferase (5 mg/mI) in a Turner TD-20e luminometer
(Turner Designs, Sunnyvale, CA, USA). The ATP content was
expressed relative to the cell protein content determined using the
BioRad Protein Assay (Bio-Rad Lab, Hercules, CA, USA).
Chromatographic separation and mass measurements of
lysoplasmalogens and monoacyllysophospholipids
Isolated rabbit proximal tubules harvested from rabbit kidney
cortex were subjected to various times of hypoxia as described
above. At the end of the incubations, normoxic and hypoxic
tubules were suspended in 2 ml phosphate buffer and 100 jxl
aliquot removed for protein analysis. The remaining cell suspen-
sion was then subjected to chloroform and methanol phospholipid
extraction according to the method of Bligh and Dyer [19].
High-performance liquid chromatography
The phospholipid extracts were taken to dryness under nitro-
gen, resuspended in 100 xl of hexane/isopropanol/water and
injected onto a silica-based column. Phospholipids were separated
from lysophospholipids using an isocratic linear gradient with a
mobile phase of hexane/isopropanol/water (46/46.5/7.0). Column
effluents corresponding to lysoplasmenylcholine and monoacyl
LPC were collected, evaporated under nitrogen and subsequently
utilized for mass measurements. The samples containing lyso-
phospholipids were incubated with [3H] acetic anhydride in the
presence of dimethylaminopyridine for 12 hours at 37°C. At the
end of this period the samples were dried under nitrogen and
lysophospholipids formed were separated by TLC. A standard
curve was prepared by adding purified 17:0 LPC in amounts
ranging from 0.5 to 15 nanomoles. The TLC plate from the
reagent blanks and the samples were scraped into liquid scintil-
lation vials and counted.
Measurement of long chain acylcarnitines in proximal tubules
Proximal tubule long chain acylcarnitines were measured as
previously described [3]. Briefly, after each experimental condi-
tion 3 mg of proximal tubule cell suspensions were added to 150
tl 70% PCA and mixed thoroughly. The suspension was centri-
fuged at 10,000 g for 30 minutes, the supernatant removed, the
pellet washed twice with 2 ml 7% PCA and the remaining pellet
resuspended in 250 pJ of distilled water for assay of the long chain
acylcarnitine fraction. Free carnitine was measured in each frac-
tion by a modification of the radioenzymatic method of McGarry
et al [3]. The reaction mixture in a final volume of 1 ml contained:
120 mol HEPES buffer pH 7.4; 1.25 mol ethylene diamine
tetra-acetic acid (EDTA); 2.0 xmol N-ethylmaleimide; 5 nmol
(0.04 Ci) 3H-acetyl CoA; and samples or standards containing 2
to 100 pmol of free carnitine. The reaction was initiated by the
addition of 50 jil of a solution prepared by diluting 400 .tl of
carnitine acetyltransferase (120 U/mg protein in 2.9 M ammonium
sulfate) and 150 d of 0,83 M HEPES buffer (pH = 7.4) to a total
volume of 2.0 ml with distilled water. Samples were incubated at
room temperature for 60 minutes. After incubation, 900 i1 from
each assay tube was transferred to a 13 X 100 mm serum
separator tube that contained 700 mg of acid washed Dowex
AG1-X8 anion exchange resin for removal of unreacted 3H-
acetyl-CoA from the reaction mixture. The serum separator tubes
were placed inside 13 x 100 mm glass culture tubes to form an
airtight seal that allowed the reaction mixtures to filter through
the anion exchange resin when the serum separator was partially
withdrawn. An additional 300 d of water was added to the resin
and the serum separator was withdrawn completely and dis-
carded. A 900 xl volume of the resin eluate was added to a 10 ml
of Econo-Safe scintillation cocktail and radioactivity in the sam-
ples was counted with a liquid scintillation counter. The concen-
tration of carnitine in each sample was determined from the least
squares linear regression analysis of samples of carnitine stan-
dards containing 20 to 100 pmol of carnitine. The results were
normalized according to the protein content of the cell suspension
measured according to Lowry [17] using bovine serum albumin as
standard.
Carnitine palmitoyl transferase(s) activities in isolated
mitochondria from rabbit proximal tubules: Preparation of
mitochondria
After hypoxic treatments, the tubule suspension was centri-
fuged at 500 g for five minutes. The pellets were rinsed once with
SET buffer (0.25 M sucrose, 1 mM EDTA, 10 msi Tris-HC1, pH
7.4) at 4°C and centrifuged again to remove the media. The pellets
were then homogenized with Teflon-glass homogenizer in SET
buffer. The mitochondria fraction was collected between 1,000 to
10,000 X g with differential centrifugation in SET buffer as
described [5]. This differential centrifugation method has been
shown to produce a highly enriched mitochondrial fraction with
negligible peroxisomal or lysosomal contamination. The enrich-
ment for mitochondrial fraction over microsomal fractions was
established using succinate dehydrogenase activities 17 3
O.D./mg protein (mitochondrial fraction) versus 0.39 0.1
O.D./mg protein (microsomal fraction) and 5' nucleotidase en-
zyme activities 0,2 0.05 O.D./mg protein (mitochondrial frac-
tion) versus 2.2 0.3 (microsomal fraction).
Assay of CPT activities
Mitochondrial CPT I activity was measured using a modified
version of a previously described method [9]. Total assay volume
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was 500 d containing 500 xM L-carnitine (including 0.125 xCi of
L-[14C] carnitine), 50 /xM palmitoyl CoA, 4 mtvt ATP, 0.25
GSH, 4 mi MgC12, 40 mg/mi rotenone, 2 mM KCN, 15 mM KC1,
1% (vol/vol) bovine serum albumin, and 105 mivi Tris-HCI (pH
7.2). Malonyl CoA was included as indicated. Reactions were
started by addition of mitochondria (in 100 pA) and were allowed
to proceed for 10 minutes (rates linear up to 15 mm). After
addition of 500 pA of 1.2 N HC1, the paimitoyl [14C] carnitine
product was extracted into 700 pA of butanol. Four hundred
microliters of the upper butanol phase were back extracted with
60 1.d of water, and 200 pJ of the final organic phase were taken for
liquid scintillation counting. Protein concentration was deter-
mined by the method of Lowry [17]. For measurements of CPT II
activity, mitochondria were made 1% (wt/vol) with octyl glucoside
and kept on ice for 30 minutes before assay, with frequent
vortexing. This procedure solubilizes CPT II in active form while
inactivating CPT I [201.
Western blot analysis for CPT I and CPT II of mitochondria
from rabbit proximal tubules
The proximal tubule mitochondrial fraction was prepared as
described above. The pellets containing mitochondrial mem-
branes (approximately 10 mg of protein) were resuspended into
1.5 ml of distilled water. A freeze-thawed treatment prior to
eiectrophoresis was conducted by keeping the vials subsequently
at 4°C for 10 minutes, at —20°C for 20 minutes, at —70°C for 20
minutes, in liquid nitrogen for five minutes, and finally back at 4°C
for 30 minutes. After vortexing vigorously, the vials were centri-
fuged at 20,000 x g for 20 minutes, The pellets of mitochondria
were then solubilized into 1.5 ml of 10 m'vi Tris-HCI containing
0.5% Triton X-100. In addition to rabbit proximal tubule mito-
chondria, mitochondrial preparations from freshly isolated rat
liver and rat kidney cortex tissues were processed in a similar
manner to the proximal tubule mitochondria and used as the
positive control for Western blotting. For SDS PAGE, 100 xg of
protein from each mitochondria preparation were precipitated
with ice-cold acetone, then solubilized into 20 pA of lx sample
buffer, heated at 90°C for three minutes, then separated on a 10%
gel with Kaleidoscope prestained standards from BioRad. The
proteins were then transferred onto a PVDF membrane, which
was blocked with 4% fat free dry milk in TBS buffer. For CPT II
detection the blocked PDVF membrane was incubated with 10 ml
of 1:500 dilution of anti-CPT II serum (RK4O) overnight at 4°C.
After serial washes with Tris-huffered saline-Tween (TBST-T),
the membrane was incubated with 10 ml of 1:5,000 dilution of
HRP conjugated goat anti-rabbit lgG (BioRad) for one hour at
room temperature, followed by ECL detection done according to
manufacturer instructions (Amersham). For CPT I detection the
membranes were incubated with 5 ml of 1:500 dilution of anti-
CPT I serum (B564) for one hour at room temperature and a
similar protocol as described for the second antibody was fol-
lowed.
Effect of hypoxia and CPT inhibition on lactic acid production
After incubation of proximal tubules under various experimen-
tal conditions the tubule suspension was pelleted at 10,000 rpm
for 10 to 15 minutes. Then 20 and 40 pJ of the supernatant were
used for lactic acid measurements. Lactic acid was measured in
proximal tubular cells according to manufacturer's recommenda-
tions (Sigma). In this assay lactic acid produced is converted to
pyruvate and hydrogen peroxide (H202) by lactate oxidase. In the
presence of the H202 formed, peroxidase catalyzes the oxidative
condensation of chromogen precursors to produce a color dye
with an absorption maximum at 540 nm. The increase in absor-
bance at 540 nm is directly proportional to lactate concentration
in the sample [211.
Effect of hypoxia and CPT inhibition on Fodrin proteolysis
At the end of each treatment, I ml of tubule suspension was
collected and centrifuged at 1,000 g for five minutes at 4°C. The
pellet was solubilized in 1 ml of 2 m Triton X-100 by vortexing.
Then 20 jxg of tubule protein from each experimental condition
was mixed with sample buffer and heated in boiling water for two
minutes before it was loaded and run on a 8% precasted Tris-
glycine gel. The proteins were then transferred to a PDVF
membrane. After blocking in 4% dry milk in TBS for one hour the
membrane was incubated in 1:5,000 diluted anti-fodrin monoclo-
nal antibody for one hour at room temperature and then in
1:10,000 diluted HRP conjugated anti-mouse IgG for 30 minutes,
followed by ECL staining. The images on the X-ray films were
scanned and printed with Foto/Analyst Fotodyne, Inc., and quan-
titated with Collage 4.0.
Statistical analysis
Paired t-tests were used to compare matched values, and
analysis of variance (ANOVA) was used for comparing different
groups. All values are expressed as mean SE, and the differences
were considered to be significant when P < 0.05.
RESULTS
CPT activity in rabbit proximal tubule mitochondria
We measured CPT I activity in isolated mitochondrial fractions
of rabbit proximal tubules. CPT I activity defined as the mito-
chondrial membrane-bound activity maximally inhibited by 100
jLM malonyl CoA was readily detected in mitochondrial fractions
of normoxic tubules (1.1 0.3 nmol/min/mg protein). Glyben-
clamide, a sulfonylurea, known to inhibit CPT I activity from heart
and liver tissue [22] caused a marked dose-dependent inhibition
of proximal tubule CPT I activity with a maximum effect at 400 xM
(0.6 0.1 nmol/min/mg protein) as shown in Figure 1A. To
measure CPT II activity the proximal tubule mitochondrial prep-
aration was solubilized with 1% (wt/vol) octyl glucoside and then
kept on ice for 30 minutes. This procedure solubilizes CPT II
protein in an active form while inactivating CPT 1 [9]. CPT II
activity, which represented the malonyl CoA-insensitive, deter-
gent-solubilized enzyme activity was also detected in proximal
tubule mitochondrial fractions (2.3 0.4 nmol/min/mg protein).
Again, the inhibition of CPT Ii activity by glybenclamide was
concentration dependent with a maximum inhibition of 70% at a
concentration of 400 bLM (0.7 0.2 nmol/min/mg protein) as
shown in Figure lB. The inhibitory effect of oxfenicine [(S-2-(4
hydroxyphenyl)-glycine] on CPT I activity could not be directly
tested in proximal tubule mitochondrial fractions, since its inhib-
itory effect requires the intracellular formation of an intermediate
ester compound (4-hydroxyphenylglyoxylate) [23]. Therefore, in
the next series of experiments in addition to glybenclamide (400
ILM), the effect of 1 mivi oxfenicine on hypoxia-induced membrane
damage in intact tubules was also tested, since this concentration
1.5
0
Glybenclamide, LM
Fig. 1. Effects of glybenclamide on proximal tubule CPT activities.
Proximal tubule mitochondrial membranes were prepared as described in
the Methods section, and exposed to various concentrations of glyben-
clamide. Values for CPT I activity (A) and CPT II activity (B) are shown
as means SD. All of the data derive from four independent experiments.
*p < 0.05 versus control.
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Fig. 2. Effect of hypoxia on CPT activity. Isolated rabbit proximal tubules
were exposed to 10, 20, and 30 minutes of hypoxia, after which mitochon-
dna! fractions were prepared as described in the Methods section. CPT I
activity (A) was measured in freshly isolated proximal tubule mitochon-
drial membrane fractions as described. CPT II activity (B) was measured
in mitochondnial membranes solubilized in 1% octyl glucoside. Both
activities are expressed as means SD. The data are derived from four
independent experiments.
A
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has been shown to be the concentration needed to inhibit CPT I
activity from heart and liver tissue [22].
Effect of hypoxia on CPT activity
Figure 2 shows the effects of hypoxia on CPT I and CPT II
activities. Baseline CPT I activity went from 1.1 0.3 (normoxia)
to 1.6 0.5 nmol/min/mg protein at the end of 30 minutes of
hypoxia. Similar results were observed for CPT II activity that
went from 2.3 0.4 (normoxia) to 2.8 0.5 nmol/min/mg protein
at the end of 30 minutes of hypoxia. CPT I and CPT II activities
did not change during 30 minutes of normoxic conditions (results
not shown). Thus, proximal tubule CPT I and CPT II activities
measured in isolated mitochondrial fractions did not change
significantly during normoxia or hypoxia.
Effect of CPT inhibition on hypoxia-induced LDH release and
ATP depletion
We examined the effect of two CPT inhibitors, glybenclamide
and oxfenicine, on hypoxia-induced membrane damage. Hypoxia
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Fig. 3. Effect of CPT inhibitors on LDH release and intracellular ATP
levels. (A) LDH release under normoxic control conditions and at 30
minutes of hypoxia in the absence and presence of glybenclamide (400 M,
Glyb) and Oxfenicine (1 mM, Oxfe). Results are means SE, N = 8, *p <
0.05 versus hypoxia. (B) ATP levels under normoxic control conditions
and at 30 minutes of hypoxia in the absence and presence of glyben-
clamide (400 .LM) and Oxfenicine (1 mM). Results are means SE, N = 8.
for 30 minutes resulted in significant LDH release (normoxia 9
1% vs. 30 mm hypoxia 46 3%). Figure 3A shows the effect of
CPT inhibitors on LDH release during hypoxia. Preincubation of
proximal tubules for 30 minutes with glybenclamide (400 ILM) or
oxfenicine (1 mM) prior to hypoxia resulted in marked reduction
in the levels of LDH released to 25 1% and 19 2%,
respectively. To determine whether the effect of CPT inhibitors
was related to differences on intracellular ATP levels during
hypoxia, we examined the effect of glybenclamide and oxfenicine
on hypoxia-induced intracellular ATP depletion. As shown in
Figure 3B ATP levels measured in normoxic tubules (6.8 0.7
nmol/mg protein) were markedly decreased at the end of 30
minutes of hypoxia (1.2 0.4 nniol/mg protein). Preincubation of
proximal tubules with CPT inhibitors prior to 30 minutes of
hypoxia did not cause a significant recovery of ATP levels during
hypoxia 1.3 0.4 (Glyb) and 1.0 0.3 nmol/mg protein (Oxfe).
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Fig. 4. Effect of CPT inhibition on hypoxia-induced lysophospholipid and
long chain acylcarnitine (LCAC) formation. Proximal tubules were incu-
bated in the absence and presence of glybenclamide (400 LM) and
oxfenicine (1 mM) for 30 minutes, and then exposed to 30 minutes of
hypoxia. Lysophospholipids and LCAC were extracted and quantified as
described in Methods section. (A) The effects of hypoxia and CPT
inhibitors on lysophospholipid formation. (B) The effects of hypoxia and
CPT inhibitors on LCAC formation. Results represent the mean SE of
four independent experiments. *D < 0.05 versus hypoxia.
Effect of CPT inhibition on hypoxia-induced lysophospholipid
formation
Since our previous studies have established a direct correlation
between hypoxia-induced membrane damage (LDH release) and
the increased formation of lysophospholipids generated via acti-
vation of intracellular PLA2 [3] in the proximal tubule, next the
effect of glybenclamide and oxfenicine on hypoxia-induced lyso-
phospholipid formation was examined. As shown in Figure 4A
hypoxia resulted in a significant increase in the mass of lysophos-
pholipids levels (control 440 105 pmol/mg protein vs. 30 mm
hypoxia 720 93 pmol/mg protein, N = 4; P < 0.05). Preincu-
bation of proximal tubules prior to hypoxia with glybenclamide
markedly decreased lysophospholipid formation (490 160
pmol/mg protein). Oxfenicine also caused marked reduction of
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hypoxia-induced lysophospholipid formation (342 150 pmol/mg
protein). These results suggest that the inhibition of lysophospho-
lipid formation may represent one of the mechanisms by which
CPT inhibitors protect during hypoxia-induced membrane dam-
age.
Effect of CPT inhibition on hypoxia-induced long chain
acylcarnitine formation
To further demonstrate that the effect of CPT inhibitors was
mediated via inhibition of long chain fatty acid oxidation, the
effect of hypoxia and CPT inhibition on long chain acylcarnitne
formation was studied. As shown in Figure 4B, hypoxia resulted in
a significant increase in the mass of long chain acylcarnitine levels
(control 79 11 vs. 30 mm hypoxia 618 34 pmol/mg protein).
Preincubation of proximal tubules with glybenclamide markedly
reduced LCAC formation (295 27 pmol/mg protein).
Oxfenicine also caused marked inhibition of LCAC formation
(128 16 pmol/mg protein). These results confirm that the
protective role of these inhibitors is due to inhibiton of CPT-
mediated long chain fatty acid oxidation.
CPT inhibition increases lactic acid levels in proximal tubules
Previous studies have suggested that the protective effect of
CPT inhibitors was related to an increase on glucose utilization by
ischemic tissue [24, 25]. This could occur by interaction of two key
enzymes which determine the rate of glucose and fatty acid
oxidation, the pyruvatc dehydrogenase (PDH) complex and the
CPT system [261. To gain insight on the mechanisms of cytopro-
tection during hypoxia, I examined the effect of CPT inhibition on
glycolysis determined by the formation of lactic acid in the
proximal tubule. Figure 5 shows the effects of hypoxia on glyco-
lytic lactate production. Glyhenclamide alone under normoxic
Fig. 6. Western blots of mitochondrial membranes from rabbit proximal
tubules, rat kidney and rat liver. The mitochondrial membranes from
rabbit proximal tubules under normoxic control conditions (lane 1), after
30 minutes of hypoxia (lane 2), rat kidney cortex (lane 3), and rat liver
(lane 4) were all probed with anti-serum raised against rat liver CPT II.
conditions stimulated lactate production in the proximal tubule,
and this effect persisted in the presence of hypoxia. Preincubation
of proximal tubules with oxfenicine caused a smaller stimulation
of lactic acid production during hypoxia. These results support the
presence of glycolysis during CPT inhibition, but do not necessar-
ily imply that this is the mechanism of protection against hypoxia-
induced membrane damage.
J CPT isoenzymes in the proximal tubule
Since previous clinical, enzymological and molecular cloning
approaches have demonstrated that within a given species mito-
chondrial carnitine palmitoyl transferase II (CPT II inner mem-
brane) exists as the same protein throughout the body, we carried
out Western blot analysis of proximal tubule mitochondrial mem-
branes using a polyclonal antibody to liver CPT II. As shown in
Figure 6, a strong band corresponding to a 70 kDa protein was
seen in the mitochondrial membranes isolated from rabbit prox-
imal tubules (lane 1). Hypoxia for 30 minutes (lane 2) resulted in
no major changes in the amount of protein detected by CPT TI
antibody. A 68 kDa protein that corresponded to CPT II in rat
kidney cortex (lane 3) and rat liver (lane 4) was also detected with
anti-CPT II antibody. By contrast, no signal representing CPT 1
protein was recognized by anti-liver CPT I in isolated tubules
(results not shown). Thus, it appears that mitochondrial mem-
branes from proximal tubules contain the liver isoform of CPT II,
whereas the CPT I isoform in the kidney was not immunologically
related to rat liver CPT I.
Fodrin proteolysis
Although hypoxia induced activation of phospholipases and
proteases has been described in isolated tubules [15, 16], there has
been no attempt to establish a possible relationship between these
two events. Previous studies have described the role of calpain in
cell death during ischemia. Activation of calpain-like proteases
during ischemia has been associated to the significant proteolysis
of fodrin an important structural cytoskeletal protein present in
mammalian cells [13, 14]. We have used a monoclonal antibody to
fodrin to determine the effects of hypoxia on fodrin proteolysis.
Lysates made from proximal tubules subjected to normoxic con-
ditions (control), and various times of hypoxia were probed for
alpha-fodrin expression by immunoblotting. Figure 7A shows a
time-dependent hydrolysis of the 240 kDa protein corresponding
to fodrin detected as early as 20 minutes of hypoxic injury. As
shown in Figure 7B, the cleavage of fodrin to a major detectable
fragment of 150 kDa during hypoxia was inhibited by preincuba-
tion of proximal tubular cells with glybenclamide, but more
dramatically by oxfenicine, a CPT inhibitor shown in our above
studies to prevent LDH release and lysophospholipid formation
during hypoxia.
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Fig. 5. Lactate production in rabbit proximal tubules. Lactate produc-
tion rates by rabbit proximal tubules in response to normoxia in the
absence (control) and presence of glybeclamide (Glyb), and 30 minutes
hypoxia in the absence (hypoxia),and presence of glybenclamide (Glyb)
and oxfenicine (Oxfc). Values arc means SE, N = 5.
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Fig. 7. Cleavage of fodrin during hypoxia and
inhibition of this cleavage under conditions in
which membrane damage is inhibited. (A)
Lysates were prepared from control normoxic
proximal tubules and from proximal tubules
subjected to various times of hypoxia. Proteins
were solubilized as described in the Methods
section and separated by SDS-polyacrylamide
gel electrophoresis followed by Western
blotting. Blots were then probed with an
antibody to the fodrin alpha subunit. The area
of the 240 kDa immunoreactive band was
scanned and quantitated as described. The
percentage of changes on the hydrolysis of the
240 kDa fodrin subunit under normoxia (LI)
and 10, 20, and 30 minutes of hypoxia (•) are
shown, N = 4. (B) Western blots from lysates
of proximal tubular cells incubated under
normoxic control conditions (lane 1) after 30
minutes of hypoxia in the absence (lane 2) and
in the presence of glybenclamide (lane 3) and
oxfenicine (lane 4) as indicated.
DISCUSSION
CPT system in the proximal tubule
Our studies have characterized two distinct CPT activities in
mitochondrial fractions of the proximal tubule. The demonstra-
tion of two measurable CPT activities agree with what is currently
known about this complex transfer system [4—12]. For example,
these data confirm the presence of a CPT I malonyl CoA-sensitive
activity that accounts for the first phase of fatty acid oxidation and
the formation of long chain acyl carnitines. Previous studies have
suggested a clear distinction between heart, skeletal muscle CPT
I activity on one hand, and liver, kidney cortex and mammary
gland CPT I activity on the other. This separation was initially
based on the degree of sensitivity to malonyl CoA, being the first
group (muscle M-CPT I isoform) more sensitive than the kidney
cortex and liver L-CPT I isoform (41. More recently, the use of
specific ligands such as 3H-tetradecylglycidyl-CoA (TG-CoA) has
permitted the CPT I isoform from heart and skeletal muscle
M-CPT Ito separate on SDS-PAGE, as a protein with a molec-
ular mass of 82,000 from the labeled CPT I from liver (Mr 88,000)
L-CPT I isoform. Our studies cannot conclusively determine
which CPT-I isoform is the one present in the proximal tubule,
however, recent data obtained by Dr. McGarry's laboratory
(personal communication) using Northern blot analysis of poly A
mRNA from rat kidney cortex, has shown that the liver L-CPT I
eDNA and not the muscle M-CPT I eDNA was the one that
readily hybridized to a 4.7 kb message in kidney cortex. Therefore,
A
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it is likely that the major CPT I isoform present in the proximal
tubules is closely related to the L-CPT I isoform. Other features
of the CPT I activity measured in proximal tubules resemble the
CPT I activity measured in liver tissue. For example, the kinetics
of inhibition by glybenclamide with a maximum inhibition at 400
/LM is similar to the one observed for liver (L-CPT-I) activity. CPT
II activity accounted for the majority of CPT activity measured in
the mitochondrial fractions of proximal tubules. Using rat liver
anti-CPT II antibodies, the presence of this CPT II activity was
correlated with immunoreactivity of rabbit proximal tubule mito-
chondrial fractions. Western blots using this antibody demon-
strated the presence of a protein of a molecular size of 70 kDa
rather than the 68 kDa protein found in the rat liver mitochon-
dna. It is likely that differences in species (rat vs. rabbit) could
account for the difference in molecular size; however to my
knowledge these present studies represent the only available
information regarding the characterization of the CPT II isoform
present in the proximal tubule. In the present studies, both
activities CPT I and II were markedly inhibited by glybenclamide,
again a feature described for the liver CPT II isoform.
Mechanisms of LCAC accumulation during hypoxia
Under the conditions used in our CPT assays we did not detect
any significant change in the activities of CPT I or CPT II during
hypoxia. Two major mechanisms that do not involve CPT enzymes
have been postulated to account for the observed accumulation of
LCAC during ischemia/hypoxia [27]. First, as acyl CoA accumu-
lates in the mitochondrial matrix, the free carnitine concentration
in the matrix is reduced by reversal of the CPT II reaction. The
reduction in the concentration of carnitine within the matrix
results in a decrease in the rate of translocation of LCAC from the
cytosol to the inner matrix of the mitochondria by carnitine-
acylcarnitine translocase. Secondly, it has been demonstrated that
the activity of carnitine-acylcarnitine translocase is markedly
decreased in mitochondria isolated from ischemic tissue as a
result of modification of protein sulthydryl groups [28]. Treatment
of these mitochondria with sulthydryl-reducing agents restores
carnitine exchange to control non-ischemic levels. Therefore,
inhibition of acylcarnitine translocation and the depletion of
matrix free carnitine are the critical events responsible for the
increase in LCAC in the cytosol during hypoxia and ischemia.
Inhibition of CPT system protects against hypoxia-induced
membrane damage
The present data demonstrate a marked protection of hypoxia-
induced membrane damage by inhibition of mitochondrial CPT
enzymes in the proximal tubule. At least four mechanisms could
account for the observed protective effect:
(1) Inhibition of CPT activity resulted in inhibition of palmitoyl
carnitine accumulation. Previous studies from our laboratory have
shown that LCAC causes marked inhibition of proximal tubule
Na,K-ATPase [3], and also appears to modulate Ca2 channel
function in other cell systems [29], mechanisms that can poten-
tially contribute to cell death. Therefore, inhibition of the forma-
tion of these toxic amphiphiles is expected to result in protection
against cell death.
(2) This study also demonstrated that CPT inhibition resulted
in inhibition of lysophospholipid formation. Lysophospholipids
accumulate during hypoxia as a result of both activation of
cytosolic PLA2 and inhibition of lysophospholipase activity [30].
Our previous studies have demonstrated the presence of a cyto-
solic and membrane-bound lysophospholipase activity in the
proximal tubule that is inhibited by LCAC. Thus, CPT inhibition
that results in inhibition of LCAC formation is expected to
preserve the function of this enzyme during hypoxia, therefore
leading to the attenuation of lysophospholipid formation. Our
results are in agreement with previous studies in the heart, where
CPT-I inhibition of cardiac myocytes was also accompanied by
marked inhibition of lysophospholipid formation and protected
against the development of arrhythmias during ischemia [27].
Therefore, our results underscore the potential toxic role of
lysophospholipid and LCAC metabolite accumulation during
hypoxic cell injury to the proximal tubule.
(3) These experiments showed increases in the levels of lactic
acid in the presence of both glyburide and oxfenicine that suggest
activation of the energy metabolic switch from lipolysis to glyco-
lysis. This metabolic switch was found to be active during kidney
development [31], however, the implications of the current find-
ings in the context of hypoxic injury are as yet unknown. The
increased glycolysis caused by glybenclamide-induced inhibition
of CPT enzymes did not correlate with the degree of inhibition of
membrane damage, when compared to oxfenicine. Therefore, it is
likely that mechanisms other than increased glycolysis could
account for the observed cytoprotection.
(4) Lastly, this study demonstrates the new finding of fodrin
proteolysis during hypoxic cell injury to the proximal tubule.
Previous studies have failed to demonstrate these changes [32].
The current study used an anti-fodrin monoclonal antibody that
recognizes changes in fodrin cleavage which accompany brain
ischemia, and apoptosis induced by activation via the CD3IT cell
receptor complex in a murine T cell hybridoma [13]. The changes
detected with this anti-fodrin antibody were corroborated in those
studies also using an antibody that specifically recognizes the
peptide, GMMPR, which corresponds to the N-terminal sequence
of the calpain I-generated fragment of fodrin [13, 14]. Since
hypoxia has been shown to induce calpain activation in proximal
tubules, the data further suggest that proteolysis of fodrin during
hypoxia, similarly to apoptosis in T cells, may be a consequence of
calpain activation. The direct consequences of fodrin proteolysis
are still unknown. However, as a major component of the
plasma-membrane associated cytoskeleton, it is possible that
fodrin cleavage during hypoxia may have implications for the
membrane blebbing seen during this process.
In summary, the current study demonstrates (1) the presence of
two proximal tubule mitochondrial CPT I and CPT II activities;
(2) inhibition of CPT enzymes in the proximal tubule is accom-
panied by protection against necrotic cell death and lysophospho-
lipid formation; (3) CPT inhibition increases glycolysis in the
proximal tubule; and that (4) hypoxic injury is associated with
fodrin proteolysis, and CPT inhibition with oxfenicine prevents
hypoxia-induced fodrin proteolysis. The observed protection
against cell death in the proximal tubule using specific CPT
inhibitors may prove to involve more complex mechanisms than
the ones described in this study. For example, it has been recently
shown in in vivo studies that the administration of CPT I inhibitors
to mice or rats resulted in tissue limited increases in steady-state
medium-chain-acyl CoA dehydrogenase (MCAD) mRNA levels.
MCAD mRNA and enzyme are expressed predominantly in
tissues that use fatty acids preferentially as energy substrates,
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including heart, liver and kidney cortex. This study also demon-
strates that MCAD was modulated postranscriptionally by a newly
discovered peroxisome proliferator activating receptor (PPAR
alpha). PPAR alpha is found expressed in the liver, kidney, brown
adipose tissue, eye, digestive tract, immune and genital systems
[331, but its function is currently unknown in the kidney. PPAR
alpha regulates the activity of several genes whose products are
associated with the entire oxidative pathway, including the uptake,
activation and oxidation (microsomal, peroxisomal and mitochon-
drial) of fatty acids, as well as ketogenesis. Thus, it is likely that
CPT inhibition produces PPAR induction via a common saturable
extramitochondrial fatty acid metabolic pathway. Current work in
progress in our laboratory is aimed to elucidate the role of PPAR
in the regulation of FA metabolism during hypoxia/ischemia in
the proximal tubule.
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